1
|
Borghi SM, Zaninelli TH, Carra JB, Heintz OK, Baracat MM, Georgetti SR, Vicentini FTMC, Verri WA, Casagrande R. Therapeutic Potential of Controlled Delivery Systems in Asthma: Preclinical Development of Flavonoid-Based Treatments. Pharmaceutics 2022; 15:pharmaceutics15010001. [PMID: 36678631 PMCID: PMC9865502 DOI: 10.3390/pharmaceutics15010001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Revised: 12/06/2022] [Accepted: 12/16/2022] [Indexed: 12/24/2022] Open
Abstract
Asthma is a chronic disease with increasing prevalence and incidence, manifested by allergic inflammatory reactions, and is life-threatening for patients with severe disease. Repetitive challenges with the allergens and limitation of treatment efficacy greatly dampens successful management of asthma. The adverse events related to several drugs currently used, such as corticosteroids and β-agonists, and the low rigorous adherence to preconized protocols likely compromises a more assertive therapy. Flavonoids represent a class of natural compounds with extraordinary antioxidant and anti-inflammatory properties, with their potential benefits already demonstrated for several diseases, including asthma. Advanced technology has been used in the pharmaceutical field to improve the efficacy and safety of drugs. Notably, there is also an increasing interest for the application of these techniques using natural products as active molecules. Flavones, flavonols, flavanones, and chalcones are examples of flavonoid compounds that were tested in controlled delivery systems for asthma treatment, and which achieved better treatment results in comparison to their free forms. This review aims to provide a comprehensive understanding of the development of novel controlled delivery systems to enhance the therapeutic potential of flavonoids as active molecules for asthma treatment.
Collapse
Affiliation(s)
- Sergio M. Borghi
- Department of Pathology, Center of Biological Sciences, Londrina State University, Londrina 86057-970, PR, Brazil
- Center for Research in Health Sciences, University of Northern Paraná, Londrina 86041-120, PR, Brazil
| | - Tiago H. Zaninelli
- Department of Pathology, Center of Biological Sciences, Londrina State University, Londrina 86057-970, PR, Brazil
| | - Jéssica B. Carra
- Department of Chemistry, State University of Londrina, Londrina 86057-970, PR, Brazil
| | - Olivia K. Heintz
- Vascular Biology Program, Boston Children’s Hospital, Department of Surgery, Harvard Medical School, Boston, MA 02115, USA
| | - Marcela M. Baracat
- Department of Chemistry, State University of Londrina, Londrina 86057-970, PR, Brazil
- Department of Pharmaceutical Sciences, Center of Health Science, Londrina State University, Londrina 86038-440, PR, Brazil
| | - Sandra R. Georgetti
- Department of Pharmaceutical Sciences, Center of Health Science, Londrina State University, Londrina 86038-440, PR, Brazil
| | - Fabiana T. M. C. Vicentini
- Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, Ribeirão Preto 14040-900, SP, Brazil
| | - Waldiceu A. Verri
- Department of Pathology, Center of Biological Sciences, Londrina State University, Londrina 86057-970, PR, Brazil
- Correspondence: or (W.A.V.); or (R.C.); Tel.: +55-43-3371-4979 (W.A.V.); +55-43-3371-2476 (R.C.); Fax: +55-43-3371-4387 (W.A.V.)
| | - Rubia Casagrande
- Department of Pharmaceutical Sciences, Center of Health Science, Londrina State University, Londrina 86038-440, PR, Brazil
- Correspondence: or (W.A.V.); or (R.C.); Tel.: +55-43-3371-4979 (W.A.V.); +55-43-3371-2476 (R.C.); Fax: +55-43-3371-4387 (W.A.V.)
| |
Collapse
|
2
|
Xia H. Extensive metabolism of flavonoids relevant to their potential efficacy on Alzheimer's disease. Drug Metab Rev 2021; 53:563-591. [PMID: 34491868 DOI: 10.1080/03602532.2021.1977316] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Alzheimer's disease (AD) is an age-related neurodegenerative disorder, the incidence of which is climbing with ever-growing aged population, but no cure is hitherto available. The epidemiological studies unveiled that chronic intake of flavonoids was negatively associated with AD risk. Flavonoids, a family of natural polyphenols widely distributed in human daily diets, were readily conjugated by phase II drug metabolizing enzymes after absorption in vivo, and glucuronidation could occur in 1 min following intravenous administration. Recently, as many as 191 metabolites were obtained after intragastric administration of a single flavonoid, indicating that other bioactive metabolites, besides conjugates, might be formed and account for the contradiction between efficacy of flavonoids in human or animal models and low systematic exposure of flavonoid glycosides or aglycones. In this review, metabolism of complete 68 flavonoid monomers potential for AD treatment, grouped in flavonoid O-glycosides, flavonoid aglycones, flavonoid C-glycosides, flavonoid dimers, flavonolignans and prenylated flavonoids according to their common structural elements, respectively, has been systematically retrospected, summarized and discussed, including their unequivocally identified metabolites, metabolic interconversions, metabolic locations, metabolic sites (regio- or stereo-selectivity), primarily involved metabolic enzymes or intestinal bacteria, and interspecies correlations or differences in metabolism, and their bioactive metabolites and the underlying mechanism to reverse AD pathology were also reviewed, providing whole perspective about advances on extensive metabolism of diverse potent flavonoids in vivo and in vitro up to date and aiming at elucidation of mechanism of actions of flavonoids on AD or other central nervous system (CNS) disorders.
Collapse
Affiliation(s)
- Hongjun Xia
- Medical College, Yangzhou University, Yangzhou, People's Republic of China
| |
Collapse
|
3
|
Li X, Xing H, Qin Z, Yang J, Wang P, Zhang X, Yao Z, Yao X. Potential metabolism determinants and drug-drug interactions of a natural flavanone bavachinin. RSC Adv 2020; 10:35141-35152. [PMID: 35515695 PMCID: PMC9056855 DOI: 10.1039/d0ra06961b] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Accepted: 09/16/2020] [Indexed: 12/26/2022] Open
Abstract
Bavachinin, a natural bioactive flavanone, is reported to have many pharmacological proprieties, especially anti-osteoporosis activity. Here we aim to determine the roles of cytochrome P450s (CYP), UDP-glucuronosyltransferases (UGT), and efflux transporters in metabolism and drug–drug interactions (DDI) of bavachinin. Phase I metabolism and glucuronidation were performed by human liver microsomes (HLM) and human intestine microsomes (HIM). Reaction phenotyping was used to identify the main CYPs and UGTs. Gene silencing methods were employed to investigate the roles of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in HeLa1A1 cells. Inhibition mechanisms towards CYPs and UGTs were explored through kinetic modeling. Three phase I metabolites (M1–M3) and one glucuronide (G1) were detected after incubation of bavachinin with HLM and HIM. The intrinsic clearance (CLint) values of M1 and G1 by HLM were 89.4 and 270.2 μL min−1 mg−1, respectively, while those of M3 and G1 by HIM were 25.8 and 247.1 μL min−1 mg−1, respectively. CYP1A1, 1A2, 1B1, 2C8, 2C19, and UGT1A1, 1A8 participated more in bavachinin metabolism. The metabolism showed marked species difference. BCRP and MRP4 were identified as the main contributors. Bavachinin displayed potent inhibitory effects against several CYP and UGT isozymes (Ki = 0.28–2.53 μM). Bavachinin was subjected to undergo metabolism and disposition by CYPs, UGTs, BCRP, MRP4, and was also a potent non-selective inhibitor against several CYPs and UGTs. Metabolism, efflux transport and drug–drug interactions of bavachinin.![]()
Collapse
Affiliation(s)
- Xinqiang Li
- Department of Pathology, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China
| | - Han Xing
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China
| | - Zifei Qin
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China
| | - Jing Yang
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China
| | - Peile Wang
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China
| | - Xiaojian Zhang
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China
| | - Zhihong Yao
- International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development Ministry of P. R. China, Jinan University Guangzhou 510632 China .,College of Pharmacy, Jinan University Guangzhou 510632 China
| | - Xinsheng Yao
- International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development Ministry of P. R. China, Jinan University Guangzhou 510632 China .,College of Pharmacy, Jinan University Guangzhou 510632 China
| |
Collapse
|
4
|
ZHOU QH, ZHU YD, ZHANG F, SONG YQ, JIA SN, ZHU L, FANG SQ, GE GB. Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus. Chin J Nat Med 2019; 17:858-870. [DOI: 10.1016/s1875-5364(19)30103-7] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2019] [Indexed: 12/13/2022]
|
5
|
Yi J, Du G, Zhao Y, Zhang L, Li B, Zhu W, Huang C, Li Y, Guo F. Bavachinin analogues as agonists of pan-peroxisome proliferator-activated receptors. Med Chem Res 2018. [DOI: 10.1007/s00044-018-2197-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Qian J, Xie F, Shi Y, Li J, Zhang L, Li Y, Guo F, Wang R. Pharmacokinetic and metabolism studies of bavachinin through ultra-high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Biomed Chromatogr 2018; 32:e4293. [DOI: 10.1002/bmc.4293] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2018] [Revised: 05/02/2018] [Accepted: 05/10/2018] [Indexed: 12/12/2022]
Affiliation(s)
- Jun Qian
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| | - Fan Xie
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| | - Yanhong Shi
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| | - Jinhang Li
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| | - Liuqiang Zhang
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| | - Yiming Li
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| | - Fujiang Guo
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| | - Rui Wang
- School of Pharmacy; Shanghai University of Traditional Chinese Medicine; Shanghai People's Republic of China
| |
Collapse
|
7
|
Pedretti A, Mazzolari A, Vistoli G, Testa B. MetaQSAR: An Integrated Database Engine to Manage and Analyze Metabolic Data. J Med Chem 2018; 61:1019-1030. [DOI: 10.1021/acs.jmedchem.7b01473] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Alessandro Pedretti
- Dipartimento
di Scienze Farmaceutiche “Pietro Pratesi”, Facoltà
di Farmacia, Università degli Studi di Milano, Via Luigi Mangiagalli 25, I-20133 Milano, Italy
| | - Angelica Mazzolari
- Dipartimento
di Scienze Farmaceutiche “Pietro Pratesi”, Facoltà
di Farmacia, Università degli Studi di Milano, Via Luigi Mangiagalli 25, I-20133 Milano, Italy
| | - Giulio Vistoli
- Dipartimento
di Scienze Farmaceutiche “Pietro Pratesi”, Facoltà
di Farmacia, Università degli Studi di Milano, Via Luigi Mangiagalli 25, I-20133 Milano, Italy
| | | |
Collapse
|